Eloralintide Clinical Trials (2026): 8 Studies for Obesity & Overweight

Where to Participate: All Eloralintide Trial Sites in the U.S. (229 sites across 36 states)

Every actively recruiting Eloralintidetrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Eloralintide clinical trials at a glance: phase × recruitment status

Recruiting Eloralintide clinical trials (6)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Eloralintide clinical trials by indication

Eloralintide pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Eloralintide trials (8)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Eloralintide clinical trials: frequently asked questions

How many Eloralintide clinical trials are there?

8 Eloralintide clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 6 are actively recruiting participants. 2 are marked completed.

Are Eloralintide clinical trials recruiting in 2026?

Yes — 6 Eloralintide trials are actively recruiting in 2026, with 229 U.S. sites across 36 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Eloralintide being studied for?

Eloralintide is being studied for Obesity, Overweight, Diabetes Mellitus, Type 2, Osteoarthritis, Overweight or Obesity and 1 more. The trials are grouped by indication on this page.

What phase is Eloralintide in?

Eloralintide clinical trials span 5 Phase 3, 1 Phase 2, 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Eloralintide clinical trials?

The lead sponsor across the most Eloralintide trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Eloralintideas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.